CRANBURY, N.J., Aug. 2, 2011 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare diseases, today announced a conference call and live audio webcast on Monday, August 8, 2011 at 5 p.m. ET to discuss financial results for the second quarter ended June 30, 2011.
